A university research consortium recently terminated its collaborative genomics agreement with a private pharmaceutical firm after the firm filed for exclusive patents on diagnostic biomarkers discovered through the shared repository. Although the founding charter permitted commercial partners to patent downstream therapeutic interventions developed independently, consortium ethicists argued that the university was morally obligated to rescind the partnership because patenting the basic diagnostic sequences themselves directly impedes subsequent noncommercial public health research by other institutions.
Which one of the following principles, if valid, most helps to justify the ethicists' reasoning?
- AAn academic institution is justified in maintaining a partnership with a commercial enterprise only if that enterprise refrains from asserting exclusive rights over any downstream products developed from joint initiatives.
- BResearch universities are morally required to prohibit commercial partners from seeking patent protection whenever an academic collaboration fails to produce independent therapeutic applications.
- An academic institution is morally obligated to terminate a collaborative research agreement if a commercial partner asserts exclusive intellectual property claims over shared discoveries in a manner that impedes noncommercial public health research.Cevap
- DCommercial partners in academic ventures must never be allowed to patent any scientific discovery unless every member institution of the consortium unanimously consents in writing.
- EAn academic institution is obligated to terminate a joint research partnership only when a partner entity directly breaches the explicit contractual terms of the governing charter.
Cevap
An academic institution is morally obligated to terminate a collaborative research agreement if a commercial partner asserts exclusive intellectual property claims over shared discoveries in a manner that impedes noncommercial public health research.
The ethicists conclude that the university had a moral duty to rescind its collaborative agreement because the pharmaceutical firm's patenting of shared biomarkers obstructed noncommercial public health research. The correct principle provides the exact sufficient rule required: whenever a private partner asserts exclusive rights over shared discoveries in a way that hinders noncommercial public health research, an academic institution is morally obligated to terminate the collaboration.
Adım Adım Çözüm
Anahtar Kavram
Sufficient normative principles bridging factual premises to ethical conclusions
Tahmini Süre:1m 45s